免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

凝胶-e Flex+凝胶OTC

K号: K192667 · 2019-10-25

申请人Gel-E, Inc.
决定日期2019-10-25
产品代码QSY
决定实质等同

器械摘要

gel-e Flex+ gel OTC is the device name listed in this FDA 510(k) record. The listed applicant is Gel-E, Inc.. It received FDA 510(k) clearance on 2019-10-25 under 510(k) number K192667. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

常见问题

What is the gel-e Flex+ gel OTC?

gel-e Flex+ gel OTC is a medical device that received FDA 510(k) clearance on 2019-10-25. The listed applicant is Gel-E, Inc.. The 510(k) number is K192667.

When did gel-e Flex+ gel OTC receive FDA 510(k) clearance?

gel-e Flex+ gel OTC received FDA 510(k) clearance on 2019-10-25, under 510(k) number K192667.

Who is the listed applicant for gel-e Flex+ gel OTC?

The FDA 510(k) record lists Gel-E, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for gel-e Flex+ gel OTC?

The FDA product code for gel-e Flex+ gel OTC is QSY.

列明Gel-E, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:QSY)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑